2025 | 2024 | 2022 | 2021 | |
|---|---|---|---|---|
€243,777,882-23.8% | €320,046,223 | — | — | |
€62,400,206-67.8% | €194,033,181+804.2% | €21,459,756>1000% | €85,525 | |
€116,659,705+115% | €54,259,498+125.7% | €24,036,458+762.1% | €2,788,007 | |
€356,695,235+21.7% | €293,101,197+410.6% | €57,403,430+113.3% | €26,908,259 | |
€17,618,833-34.6% | €26,927,044+204% | €8,858,998-31% | €12,848,529 | |
19.8+21.5% | 16.3-8.4% | 17.8-6.8% | 19.1 | |
€12,312,014-37.3% | €19,634,738 | — | — |
TELIX INNOVATIONS.
BE 0627.636.718.
Naamloze vennootschap (NV) / Société anonyme (SA).
Corporate structure data isn't available for ADVANCED NUCLEAR MEDICINE INGREDIENTS right now.
ADVANCED NUCLEAR MEDICINE INGREDIENTS was founded on 27 Mar 2015, making it 11 years old.
Yes, ADVANCED NUCLEAR MEDICINE INGREDIENTS is currently active.
ADVANCED NUCLEAR MEDICINE INGREDIENTS's registered main activities are Research and experimental development on biotechnology and Manufacture of basic pharmaceutical products. It is also registered for 10 additional activities.
ADVANCED NUCLEAR MEDICINE INGREDIENTS's registered address is Rue de Hermée 255, 4040 Herstal, Belgium.
Based on its most recently filed annual accounts (fiscal year ending 31 Dec 2025), ADVANCED NUCLEAR MEDICINE INGREDIENTS reported 19.8 full-time equivalent employees.
ADVANCED NUCLEAR MEDICINE INGREDIENTS's most recently filed annual turnover (fiscal year ending 31 Dec 2025) was €243,777,882.
ADVANCED NUCLEAR MEDICINE INGREDIENTS's most recently filed annual accounts (fiscal year ending 31 Dec 2025) reported a profit of €62,400,206.
ADVANCED NUCLEAR MEDICINE INGREDIENTS's most recently filed annual accounts cover the fiscal year ending 31 Dec 2025.
We have no B Corp certification on file for ADVANCED NUCLEAR MEDICINE INGREDIENTS.
No, ADVANCED NUCLEAR MEDICINE INGREDIENTS does not currently hold Fairtrade certification.
VLAAMS INSTITUUT VOOR BIOTECHNOLOGIE - FLANDERS INSTITUTE FOR BIOTECHNOLOGY
BE 0456.343.923
Suzanne Tassierstraat 1, 9052 Gent
VLAAMS INSTITUUT VOOR BIOTECHNOLOGIE - FLANDERS INSTITUTE FOR BIOTECHNOLOGY
Suzanne Tassierstraat 1, 9052 Gent
1995
BE 0456.343.923
AJINOMOTO OMNICHEM
BE 0403.078.352
Cooppallaan 91, 9230 Wetteren
AJINOMOTO OMNICHEM
Cooppallaan 91, 9230 Wetteren
1946
BE 0403.078.352
KANEKA EUROGENTEC
BE 0427.348.346
Rue du Bois St-Jean 5, 4102 Seraing
KANEKA EUROGENTEC
Rue du Bois St-Jean 5, 4102 Seraing
1985
BE 0427.348.346
BELDICO
BE 0432.680.178
Aye, Rue André Feher 3, 6900 Marche-en-Famenne
BELDICO
Aye, Rue André Feher 3, 6900 Marche-en-Famenne
1987
BE 0432.680.178
PolyPeptide
BE 0879.346.768
Chaussée de Tubize 297, 1420 Braine-l'Alleud
PolyPeptide
Chaussée de Tubize 297, 1420 Braine-l'Alleud
2006
BE 0879.346.768
SOPACHEM
BE 0407.132.457
Pluim(Z) 20, 8550 Zwevegem
SOPACHEM
Pluim(Z) 20, 8550 Zwevegem
1970
BE 0407.132.457
NANOCYL
BE 0476.998.785
Rue de l'Essor 4, 5060 Sambreville
NANOCYL
Rue de l'Essor 4, 5060 Sambreville
2002
BE 0476.998.785
AQUILON PHARMACEUTICALS
BE 0540.870.218
Rue du Bois St-Jean 15/1, 4102 Seraing
AQUILON PHARMACEUTICALS
Rue du Bois St-Jean 15/1, 4102 Seraing
2013
BE 0540.870.218
POULPHARM
BE 0888.282.250
Kokelarestraat 83, 8870 Izegem
POULPHARM
Kokelarestraat 83, 8870 Izegem
2007
BE 0888.282.250
UNISENSOR
BE 0462.139.177
Rue Louis Plescia 8, 4102 Seraing
UNISENSOR
Rue Louis Plescia 8, 4102 Seraing
1997
BE 0462.139.177
Lakefront Biotherapeutics
BE 0466.460.429
Schaliënhoevedreef 20T, 2800 Mechelen
Lakefront Biotherapeutics
Schaliënhoevedreef 20T, 2800 Mechelen
1999
BE 0466.460.429
LABO PHYTOPHAR NV
BE 0466.063.323
Handelsstraat 19, 8020 Oostkamp
LABO PHYTOPHAR NV
Handelsstraat 19, 8020 Oostkamp
1999
BE 0466.063.323
BIO MINERALS
BE 0451.906.964
Zenderstraat 12, 9070 Destelbergen
BIO MINERALS
Zenderstraat 12, 9070 Destelbergen
1994
BE 0451.906.964
BAXTER R AND D EUROPE
BE 0419.859.253
Boulevard René Branquart(L) 80, 7860 Lessines
BAXTER R AND D EUROPE
Boulevard René Branquart(L) 80, 7860 Lessines
1979
BE 0419.859.253
Laboratoires Pharmaceutiques Trenker
BE 0423.960.076
Avenue Thomas Edison 32, 1402 Nivelles
Laboratoires Pharmaceutiques Trenker
Avenue Thomas Edison 32, 1402 Nivelles
1983
BE 0423.960.076
Biotec
BE 0414.938.680
Chaussée de Louvain 656, 1380 Lasne
Biotec
Chaussée de Louvain 656, 1380 Lasne
1975
BE 0414.938.680
ABLYNX
BE 0475.295.446
Technologiepark-Zwijnaarde 21, 9052 Gent
ABLYNX
Technologiepark-Zwijnaarde 21, 9052 Gent
2001
BE 0475.295.446
iTeos Belgium
BE 0838.316.659
Rue de Venise 21, 6040 Charleroi
iTeos Belgium
Rue de Venise 21, 6040 Charleroi
2011
BE 0838.316.659
Catalent Gosselies
BE 0840.843.708
Rue Auguste Piccard 37, 6041 Charleroi
Catalent Gosselies
Rue Auguste Piccard 37, 6041 Charleroi
2011
BE 0840.843.708
Fyteko
BE 0552.915.242
Allée de la Recherche 4, 1070 Anderlecht
Fyteko
Allée de la Recherche 4, 1070 Anderlecht
2014
BE 0552.915.242
Rue de Hermée 255, 4040 Herstal, Belgium
Open in Google MapsShowing 1 of 1 locations.
2025 | 2024 | 2022 | 2021 | |
|---|---|---|---|---|
| Income statement | ||||
€243,777,882-23.8% | €320,046,223 | — | — | |
— | — | €49,606,774>1000% | €2,451,540 | |
€6,264,152+113.2% | €2,937,876+13.1% | €2,596,744+8.9% | €2,385,146 | |
— | — | €213,047+26.8% | €167,987 | |
€106,175,506-49.9% | €212,155,858+839.8% | €22,574,340>1000% | -€1,164,706 | |
€184,238,401-16.7% | €221,162,586+837.1% | €23,600,080>1000% | €59,299 | |
€62,400,206-67.8% | €194,033,181+804.2% | €21,459,756>1000% | €85,525 | |
€38,031,445-27.6% | €52,542,330>1000% | €2,262,598 | — | |
| Profitability | ||||
75.6%+9.4% | 69.1% | — | — | |
25.6%-57.8% | 60.6% | — | — | |
53.5%-85% | 357.6%+300.5% | 89.3%>1000% | 3.1% | |
13.2%-76.4% | 55.9%+112% | 26.4%>1000% | 0.3% | |
| Solvency | ||||
€473,354,940+36.3% | €347,360,696+326.5% | €81,439,888+174.2% | €29,696,266 | |
€187,413-47.9% | €359,639-20.4% | €451,804+30.2% | €347,000 | |
€4,532-4.8% | €4,7620% | €4,762+619.3% | €662 | |
€116,659,705+115% | €54,259,498+125.7% | €24,036,458+762.1% | €2,788,007 | |
24.6%+57.8% | 15.6%-47.1% | 29.5%+214.4% | 9.4% | |
€1,330,783+534.5% | €209,736-99.2% | €25,871,833+7.6% | €24,053,628 | |
0.01+195.1% | 0.00-99.6% | 1.08-87.5% | 8.63 | |
€356,695,235+21.7% | €293,101,197+410.6% | €57,403,430+113.3% | €26,908,259 | |
3.06-43.4% | 5.40+126.2% | 2.39-75.3% | 9.65 | |
2853.95-57% | 6638.70 | — | — | |
| Liquidity | ||||
€17,618,833-34.6% | €26,927,044+204% | €8,858,998-31% | €12,848,529 | |
€12,547,341-10.2% | €13,980,238>1000% | €834,944-13.7% | €967,855 | |
€33,884,293-80.4% | €173,036,004+502.9% | €28,701,361>1000% | €2,463,309 | |
€165,471,270+86.7% | €88,640,604+213.7% | €28,256,934>1000% | €2,246,296 | |
€355,019,432+21.4% | €292,549,415+838% | €31,189,551+992.6% | €2,854,631 | |
0.14-82% | 0.79-19.2% | 0.97-22.7% | 1.26 | |
-€287,475,865-704.4% | -€35,739,792-547.3% | €7,990,224-41.2% | €13,584,790 | |
| Efficiency | ||||
51 days-74.3% | 197 days | — | — | |
427 days+44.1% | 297 days | — | — | |
378 days+70.2% | 222 days | — | — | |
0.91-70.6% | 3.10 | — | — | |
| Profit appropriation | ||||
€0-100% | €230,297,326 | — | — | |
€412,0000% | €412,0000% | €412,000 | — | |
€112,049,905+125.7% | €49,649,698+160.8% | €19,037,979>1000% | -€2,009,776 | |